Reuters first to report OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe | Reuters News Agency

Reuters first to report OxyContin maker Purdue is ‘Pharma Co X’ in U.S. opioid kickback probe

Reuters broke the news that OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed recently in a probe of illegal kickbacks from drugmakers. Purdue Pharma, which faces U.S. Justice Department probes and sprawling litigation over allegations that it played a central role in the deadly U.S. opioid crisis, is facing new scrutiny in connection with a case unveiled by Vermont federal prosecutors against a San Francisco electronic health records vendor

Article Tags
Type: Reuters Best
Sectors: Equities
Regions: Americas
Win Types: Exclusivity
Story Types: Exclusive / Scoop
5e3c7b4c-0d7c-4575-90ee-23a1ac130004
Sign up for email updates
Subscribe
Sign up for email updates